HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ®

First Page		Document Content
Date: 2011-12-23 12:58:35 Gilead Sciences Carbamates Non-nucleoside reverse transcriptase inhibitors Integrase inhibitors Raltegravir Tenofovir Efavirenz Darunavir Antiretroviral drug Chemistry Organic chemistry Organofluorides		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ® Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 276,88 KB Share Document on Facebook

	BMS_Gilead_Logo_FINAL.eps DocID: 1m38a - View Document
	New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension Nevirapine DocID: 1gvCL - View Document
	Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine Information DocID: 1gtrY - View Document
	ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL DocID: 1fNy0 - View Document
	1 DECEMBER Correspondence HIV-1 Genotypic DrugResistance Interpretation Algorithms Need to Include HypersusceptibilityAssociated Mutations DocID: 1fw0V - View Document